COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,755 Articles (22,943 medRxiv, 8,812 bioRxiv)

Most recent first Previous |  Page 2044: Articles 20431-20440  | Next

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
Tarke, A., Sidney, J., Kidd, C. K., Dan, J. M., Ramirez, S. I., Yu, E. D., Mateus, J., da Silva Antunes, R., Moore, E., Rubiro, P., Methot, N., Phillips, E. J., Mallal, S., Frazier, A., Rawlings, S., Greenbaum, J. A., Peters, B., Smith, D. M., Crotty, S., Weiskopf, D., Grifoni, A., Sette, A.
10.1101/2020.12.08.416750 — Posted: 2020-12-09
Positive correlation between long term emission of several air pollutants and COVID-19 deaths in Sweden
Helander, L.
10.1101/2020.12.05.20244418 — Posted: 2020-12-09
Role of favipiravir in the treatment of adult patients with moderate to severe COVID-19: a single-center, prospective, observational, sequential cohort study from Hungary
SZABO, B. G., LENART, K. S., PETRIK, B., GASPAR, Z., BALOGH, Z., BANYAI, Z., BANYASZ, E., BUDAI, J., CZEL, E., FRIED, K., HANUSKA, A., KISS-DALA, N., LORINCZI, C., NEMESI, K., KADAR, J., NAGY, E. L., OSVALD, A., PETROVICZ, E., RICZU, A., SZANKA, J., SZATHMARY, B., SZOMBATI, A., TOTH, S., VARNAI, Z., WOLLER, O., SZLAVIK, J., LAKATOS, B.
10.1101/2020.11.26.20238014 — Posted: 2020-12-09 Discussion: Onsite
Efficacy of pulmonary rehabilitation in severe and critical-ill COVID-19 patients: a controlled study
Buesching, G., Zhang, Z., Schmid, J. P., Sigrist, T., Khatami, R.
10.1101/2020.12.08.20245936 — Posted: 2020-12-09
Prevalence of anxiety and depressive symptoms among physicians during the COVID-19 pandemic in Bangladesh: a cross-sectional study
Hasan, M. T., Hossain, S., Safa, F., Anjum, A., Khan, A. H., Koly, K. N., Alam, S. F., Rafi, M. A., Podder, V., Trisa, T. I., Nury Nodi, R., Azad, D. T., Ashraf, F., Akther, S. M. Q., Ahmed, H. U., Rosenbaum, S., Thornicroft, G.
10.1101/2020.12.08.20245829 — Posted: 2020-12-09
A Selective Increase in OC Symptoms is Driving Information Seeking and Guideline Adherence During the Covid-19 Pandemic
Loosen, A. M., Skvortsova, V., Hauser, T. U.
10.1101/2020.12.08.20245803 — Posted: 2020-12-09
Neighbourhood-level Racial/Ethnic and Economic Inequities in COVID-19 Burden Within Urban Areas in the US and Canada
Saha, S., Feldman, J. M.
10.1101/2020.12.07.20241018 — Posted: 2020-12-09
The Impacts of Testing Cadence, Mode of Instruction, and Student Density on Fall 2020 COVID-19 Rates On Campus
Stubbs, C. W., Springer, M., Thomas, T. S.
10.1101/2020.12.08.20244574 — Posted: 2020-12-09
A novel multi-omics-based identification of symptoms, comorbid conditions, and possible long-term complications in COVID-19
Barh, D., Tiwari, S., Andrade, B. S., Weener, M. E., Goes-Neto, A., Azevedo, V., Ghosh, P., Ganguly, N. K.
10.1101/2020.12.08.20245753 — Posted: 2020-12-09
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany - a cross sectional study
Thielecke, M., Theuring, S., van Loon, W., Hommes, F., Mall, M. A., Rosen, A., Boehringer, F., von Kalle, C., Kirchberger, V., Kurth, T., Seybold, J., Mockenhaupt, F. P., BECOSS Study Group
10.1101/2020.12.08.20245910 — Posted: 2020-12-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).